This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Other. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: The Innovations of Bin Ju
Introduction
Bin Ju is a notable inventor based in Shenzhen, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for combating viral infections. His work is crucial in the ongoing fight against diseases caused by SARS-CoV-2.
Latest Patents
One of Bin Ju's most important patents is titled "Anti-SARS-COV-2 antibodies and uses thereof." This patent describes modified anti-SARS-CoV-2 antibodies or antigen binding fragments that have an extended half-life and optimized immune activities. The patent also includes pharmaceutical compositions that utilize these antibodies and outlines methods for treating or preventing diseases in human patients related to SARS-CoV-2 infection.
Career Highlights
Throughout his career, Bin Ju has focused on innovative solutions to pressing health challenges. His research has led to advancements in antibody technology, which are essential for developing effective treatments against viral infections. His dedication to improving human health through scientific research is commendable.
Collaborations
Bin Ju has collaborated with several professionals in his field, including Zheng Zhang and Linqi Zhang. These collaborations have enhanced the scope and impact of his research, contributing to the development of effective therapeutic solutions.
Conclusion
Bin Ju's work exemplifies the importance of innovation in the fight against viral diseases. His contributions to antibody development are vital for improving treatment options for patients affected by SARS-CoV-2. His ongoing research continues to inspire advancements in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile